Beckman Coulter, Inc. – FDA 483, Dec 13, 2024
Beckman Coulter, Inc. in Chaska, MN, was inspected regarding its manufacturing of immunoassays and immunoassay instruments. The inspection revealed significant deficiencies in the firm's risk analysis processes, including inadequate probability definitions and failure to follow internal protocols for expert review. Additionally, the firm's complaint handling procedures were found to be insufficient, particularly concerning the investigation of instrument malfunctions and the classification and reportability of complaints involving delayed assay results.
- Person
ID · ce5f4dd4-9fe4-4ee0-8eb5-bf1928792790
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.